Literature DB >> 28188570

Recruiting Endometrial Cancer Survivors to Studies Examining Lifestyle Behaviors and Quality of Life: Challenges Faced and Lessons Learned.

Alexander R Lucas1, Brian C Focht2, David E Cohn3, Maryanna D Klatt4, Janet Buckworth5.   

Abstract

There are a growing number of cancer survivors in the USA. Despite lifestyle behaviors being strongly associated with morbidity and mortality following primary treatment, recruitment to clinical research studies that aim to improve such behaviors remains a significant challenge. Furthermore, pilot and feasibility studies are critical for the refinement of research methods and form an important training opportunity for early career scientists. This report details the challenges faced and lessons learned in the process of recruiting a population of overweight/obese endometrial cancer survivors (ECS) to two separate studies focused on lifestyle behaviors: a survey study and a randomized behavioral intervention study that aimed to improve diet, physical activity, and quality of life. We used in-clinic and mail-based approaches to reach eligible patients identified from clinic records. Surveys were offered via paper or online. To evaluate the recruitment process, we compared clinic records and enrollment data over time and location. Chi-squared tests were also used to compare recruitment strategies. We address specific challenges at the patient level, the clinic/provider level, and the organizational level. Overall response rate was 13.9% to the survey and 4% to the intervention. Responses to in-clinic offers were greater than to mail-based approaches for the survey with no difference for the intervention. Identifying the unique characteristics of each survivorship population, adequate planning, resource allocation, and involvement of key staff are essential to supporting recruitment efforts to research studies. Having the support of physicians and nurses is especially critical to the success of recruitment.

Entities:  

Keywords:  Diet; Endometrial cancer; Lifestyle behaviors; Obesity; Physical activity; Recruitment; Survivorship

Mesh:

Year:  2018        PMID: 28188570      PMCID: PMC5552444          DOI: 10.1007/s13187-017-1187-6

Source DB:  PubMed          Journal:  J Cancer Educ        ISSN: 0885-8195            Impact factor:   2.037


  23 in total

1.  Endometrial cancer survivors' assessment of the benefits of exercise.

Authors:  Jessica Lukowski; Karen M Gil; Eric Jenison; Michael Hopkins; Karen Basen-Engquist
Journal:  Gynecol Oncol       Date:  2011-11-07       Impact factor: 5.482

2.  Clinical trials: the challenge of recruitment and retention of participants.

Authors:  Raisa B Gul; Parveen A Ali
Journal:  J Clin Nurs       Date:  2010-01       Impact factor: 3.036

3.  Associations among exercise, body weight, and quality of life in a population-based sample of endometrial cancer survivors.

Authors:  Kerry S Courneya; Kristina H Karvinen; Kristin L Campbell; Robert G Pearcey; George Dundas; Valerie Capstick; Katia S Tonkin
Journal:  Gynecol Oncol       Date:  2005-05       Impact factor: 5.482

4.  Accrual to clinical trials: let's look at the physicians.

Authors:  Lori M Minasian; Ann M O'Mara
Journal:  J Natl Cancer Inst       Date:  2011-02-11       Impact factor: 13.506

5.  Morbidly obese women with and without endometrial cancer: are there differences in measured physical fitness, body composition, or hormones?

Authors:  Susan C Modesitt; Dyanna L Geffel; Jennifer Via; Arthur L Weltman
Journal:  Gynecol Oncol       Date:  2011-11-18       Impact factor: 5.482

6.  A population-based assessment of specialty physician involvement in cancer clinical trials.

Authors:  Carrie N Klabunde; Nancy L Keating; Arnold L Potosky; Anita Ambs; Yulei He; Mark C Hornbrook; Patricia A Ganz
Journal:  J Natl Cancer Inst       Date:  2011-02-11       Impact factor: 13.506

7.  Limited public knowledge of obesity and endometrial cancer risk: what women know.

Authors:  Pamela T Soliman; Roland L Bassett; Erik B Wilson; Stephanie Boyd-Rogers; Kathleen M Schmeler; Michael R Milam; David M Gershenson; Karen H Lu
Journal:  Obstet Gynecol       Date:  2008-10       Impact factor: 7.661

8.  Cancer prevalence in the United Kingdom: estimates for 2008.

Authors:  J Maddams; D Brewster; A Gavin; J Steward; J Elliott; M Utley; H Møller
Journal:  Br J Cancer       Date:  2009-06-30       Impact factor: 7.640

9.  Feasibility and effectiveness of a lifestyle intervention program in obese endometrial cancer patients: a randomized trial.

Authors:  Vivian E von Gruenigen; Kerry S Courneya; Heidi E Gibbons; Mary Beth Kavanagh; Steven E Waggoner; Edith Lerner
Journal:  Gynecol Oncol       Date:  2008-02-19       Impact factor: 5.482

10.  The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: summary and recommendations.

Authors:  Andrea M Denicoff; Worta McCaskill-Stevens; Stephen S Grubbs; Suanna S Bruinooge; Robert L Comis; Peggy Devine; David M Dilts; Michelle E Duff; Jean G Ford; Steven Joffe; Lidia Schapira; Kevin P Weinfurt; Margo Michaels; Derek Raghavan; Ellen S Richmond; Robin Zon; Terrance L Albrecht; Michael A Bookman; Afshin Dowlati; Rebecca A Enos; Mona N Fouad; Marjorie Good; William J Hicks; Patrick J Loehrer; Alan P Lyss; Steven N Wolff; Debra M Wujcik; Neal J Meropol
Journal:  J Oncol Pract       Date:  2013-10-15       Impact factor: 3.840

View more
  2 in total

1.  Continuous, objective measurement of physical activity during chemotherapy for breast cancer: the Activity in Treatment pilot study.

Authors:  Sandahl H Nelson; Lauren S Weiner; Loki Natarajan; Barbara A Parker; Ruth E Patterson; Sheri J Hartman
Journal:  Transl Behav Med       Date:  2020-10-08       Impact factor: 3.046

Review 2.  The Role of Emotion-Related Abilities in the Quality of Life of Breast Cancer Survivors: A Systematic Review.

Authors:  Ilaria Durosini; Stefano Triberti; Lucrezia Savioni; Valeria Sebri; Gabriella Pravettoni
Journal:  Int J Environ Res Public Health       Date:  2022-10-04       Impact factor: 4.614

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.